12/10/2015
Federal Register Notice: FDA has determined the regulatory review period for Napo Pharmaceuticals’ Fulyzaq is 7,784 days for...12/03/2015
Federal Register Notice: FDA is making available a draft document entitled Recommendations for Assessment of Blood Donor Suitabili...12/01/2015
Federal Register Notice: FDA is making available a draft guidance for industry entitled Veterinary Feed Directive Common Format Qu...11/18/2015
Federal Register Notice: FDA’s proposed collection of information, “Guidance for Industry on Tropical Disease Priority...11/18/2015
Federal Register Notice: FDA is seeking public comments on a proposed collection of information on the use of the FDA Electronic S...11/18/2015
Federal Register Notice: FDA is making available a guidance for industry entitled Formal Meetings Between the FDA and Biosimilar B...11/18/2015
Federal Register Notice: FDA is publishing a list of PMAs that have been approved and is informing the public of the availability ...11/17/2015
Federal Register Notice: FDA is making available a guidance for industry entitled Organ-Specific Warnings: Internal Analgesic, Ant...